Insights from 2023 ASCO® Annual Meeting

 

Insights from 2023 ASCO® Annual Meeting
P

ASCO® 2023 Summary: "Key H&N Cancer Studies Including FRAIL-IMMUNE & DEPEND"

By Insights from 2023 ASCO® Annual Meeting FEATURING Paolo Bossi
By Insights from 2023 ASCO® Annual Meeting FEATURING Paolo Bossi
938 views
June 16, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

17:48
Exelixis

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma With Mul…

Feat. R. Alter, A. Rezazadeh

Featured Video

18:17
Exelixis

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss
Head and Neck
06:27

Enfortumab Vedotin in the Previously Treated Advanced Head & Neck Ca…

Insights from 2023 ASCO® Annual Meeting

P. Swiecicki

233 views
09:16

ASCO® 2023 Insights: "Phase 3 Double-Blinded Randomized Controlled T…

Insights from 2023 ASCO® Annual Meeting

E. Cathcart-Rake

77 views
13:06

ASCO® 2023 Summary: "Key H&N Cancer Studies Including FRAIL-IMMUNE &…

Insights from 2023 ASCO® Annual Meeting

P. Bossi

938 views
15:11

Immunotherapy Trials for Nasopharyngeal Cancers

Insights from 2023 ASCO® Annual Meeting

N. Saba

402 views